Skip to content

Clinical trials

Phase 1 Neurotoxicity Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurotoxicity Syndromes Phase: Phase 1 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20091
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group1
Masonic Cancer Center, University of Minnesota1
National Cancer Institute (NCI)1
Northwestern University1
UNC Lineberger Comprehensive Cancer Center1
Vanderbilt-Ingram Cancer Center1
Wake Forest University Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurotoxicity Syndromes7
Central Nervous System Neoplasms3
Lymphoma3
Radiation Injuries2
Astrocytoma1
Brain Neoplasms1
Brenner Tumor1
Choroid Plexus Neoplasms1
Cytokine Release Syndrome1
Fallopian Tube Neoplasms1

Trials

Showing 51 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.